Outcomes of Patients Treated With RCHOP With a PET-Adapted Approach for Consolidative Radiotherapy: A Retrospective Single-Center Study at the Royal Marsden Hospital.
暂无分享,去创建一个
M. Gleeson | A. Wotherspoon | B. Sharma | I. Chau | A. Attygalle | S. Iyengar | V. Michalarea | D. El-Sharkawi | D. Cunningham | Yong Du | K. Vroobel | A. Kuhnl | L. Hickmott | Su Li | Siraj Yusuf | Simon O'Connor
[1] S. Barrington,et al. Observation vs. radiotherapy in primary mediastinal B-cell lymphoma patients with complete response to standard immunochemotherapy: The IELSG37 randomized trial. , 2023, Journal of Clinical Oncology.
[2] F. Cavalli,et al. IMPACT OF DIFFERENT INDUCTION REGIMENS ON THE OUTCOME OF PRIMARY MEDIASTINAL B CELL LYMPHOMA IN THE PROSPECTIVE IELSG 37 TRIAL , 2021, Hematological Oncology.
[3] D. Scott,et al. Outcome of Primary Mediastinal Large B-cell Lymphoma Using R-CHOP: Impact of a PET Adapted Approach. , 2020, Blood.
[4] W. Wilson,et al. End-of-treatment and serial PET imaging in primary mediastinal B-cell lymphoma following dose-adjusted EPOCH-R: a paradigm shift in clinical decision making , 2018, Haematologica.
[5] M. Gleeson,et al. Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (R‐CHOP) in the management of primary mediastinal B‐cell lymphoma: a subgroup analysis of the UK NCRI R‐CHOP 14 versus 21 trial , 2016, British journal of haematology.
[6] R. Fisher,et al. Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] Bruce D Cheson,et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] Elaine S. Jaffe,et al. Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma. , 2013, The New England journal of medicine.
[9] Elias Campo,et al. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. , 2011, Blood.
[10] M. Pfreundschuh,et al. Primary mediastinal B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: results of the Mabthera International Trial Group study. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.
[11] R. Tsang,et al. Salvage chemotherapy and autologous stem cell transplantation are inferior for relapsed or refractory primary mediastinal large B-cell lymphoma compared with diffuse large B-cell lymphoma , 2008, Leukemia & lymphoma.
[12] Klemens Scheidhauer,et al. Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] J. Manning,et al. The outcome of combined-modality treatments for stage I and II primary large B-cell lymphoma of the mediastinum. , 2000, International journal of radiation oncology, biology, physics.
[14] M. Paulli,et al. Treatment outcome and prognostic factors for primary mediastinal (thymic) B-cell lymphoma: a multicenter study of 106 patients. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] P. Zinzani,et al. Positron Emission Tomography/Computed Tomography Assessment After Immunochemotherapy and Irradiation Using the Lugano Classification Criteria in the IELSG-26 Study of Primary Mediastinal B-Cell Lymphoma. , 2017, International journal of radiation oncology, biology, physics.